搜尋結果
FTC Warns ‘Junk Patents’ Could Make Drugs Like Ozempic Pricier—Here’s How
Forbes· 3 日前The FTC sent warning letters to 10 pharmaceutical companies—including Novo Nordisk, ...
California Cuts Cost of Overdose-Reversal Drug by 40% in Generic Deal
Bloomberg· 4 日前... efforts to combat surging opioid-related deaths by teaming with a maker of generic< ... ...
Novartis to buy radiology specialist Mariana Oncology for $1 billion
Reuters· 22 小時前Novartis has entered an agreement to acquire US radiopharmaceutical company Mariana Oncology ...
Cardinal Health lifts 2024 profit view on demand for costly specialty drugs
Reuters· 21 小時前, opens new tab raised its annual profit forecast on Thursday, betting on strength in its pharmaceutical unit selling costly ...
Cencora beats profit estimates on strong demand for costly specialty drugs
Reuters· 2 日前, opens new tab beat Wall Street estimates for second-quarter profit on Wednesday, driven by robust demand for costly specialty ...
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's ...
CNBC· 3 日前The Federal Trade Commission on Tuesday said it is challenging hundreds of alleged ...
Global Inequities In Access To Drugs Costs Millions Of Lives Each Year
Forbes· 5 日前Barriers to access to these medicines disproportionately affect people in low- and ...
White House Aims to Reclassify Marijuana as Less Dangerous Drug - What’s News - WSJ Podcasts
The Wall Street Journal· 3 日前... Fertoli: The Biden administration wants to reclassify marijuana as a less dangerous drug. ...
Walmart to shutter health centers, virtual care service in latest failed push into health care
CNBC· 3 日前Walmart on Tuesday said it will close all of its health-care clinics across the country, a ...
Bausch Health investors are left in a holding pattern as 2 major overhangs remain unresolved
CNBC· 15 小時前Bausch Health Companies on Tuesday morning reported first-quarter top- and bottom-line misses — ...